Root, Inc. current report, 11 August 2021

Root, Inc. Form 8-K Summary

Business context and reporting period

Root, Inc. filed a Form 8-K dated August 11, 2021, announcing a proposed strategic investment and commercial partnership with Carvana Group, LLC. This is a transaction announcement rather than a periodic financial report; the filing does not provide current-period revenue, earnings, cash flow, margin, debt, or liquidity results.

Transaction and key financial terms

  • Carvana agreed to invest approximately $126 million in Root at closing.
  • Root will issue Series A Convertible Preferred Stock with an initial liquidation preference of approximately $126 million, convertible at $9.00 per share into approximately 14 million Class A common shares, representing 5.0% of fully diluted shares as of August 11, 2021.
  • Root will issue eight warrant tranches. If fully exercised for cash, the warrants would allow Carvana to purchase approximately 129 million Class A shares, representing 29.9% of fully diluted shares as of August 11, 2021. Exercise prices range from $10.00 to $30.00 and are subject to performance and other conditions.
  • The preferred stock is perpetual, ranks senior to common stock, and generally carries no dividends. A 5.0% annual dividend may become payable after specified conditions and timing following the Reference Date.
  • The transaction is expected to provide cash financing, but the filing does not state the intended use of proceeds or quantify any effect on Root’s debt or liquidity balances.

Material changes versus the prior comparable period

The filing does not present comparative operating or financial data. The material development is the proposed equity financing, potential dilution, and strategic relationship with Carvana.

  • At closing, Root and Carvana subsidiaries are expected to enter into a five-year exclusive partnership to develop an integrated automobile insurance solution for Carvana’s online vehicle-buying platform.
  • Root expects the partnership to increase gross written premium growth and materially reduce customer acquisition costs, but no quantified targets or guidance are provided.
  • Carvana is expected to receive governance, consent, and registration rights, including the right to appoint Carvana CEO Ernest Garcia III to Root’s board while Carvana beneficially owns the preferred stock.

Outlook, risks, and contingencies

  • Closing was expected within 45–60 days of August 11, 2021, subject to conditions including expiration of the applicable Hart-Scott-Rodino antitrust waiting period. Either party could terminate if closing had not occurred by February 11, 2022.
  • The commercial agreement includes remedies for exclusivity breaches, including fees and potential forfeiture or vesting of performance-based warrant tranches.
  • Preferred stock will be mandatorily convertible or redeemable upon a change of control, and Carvana will have voting rights on an as-converted basis plus limited separate-class voting rights.
  • Carvana agreed to five-year standstill and transfer restrictions, subject to exceptions. Regulatory filings may be required if conversion or warrant exercise would cause Carvana to hold more than 9.9% of Root’s voting stock.
  • Key risks include failure to satisfy closing conditions, regulatory delays or rejection, inability to implement the integrated platform, failure to achieve expected premium growth or customer acquisition cost reductions, dilution from conversion or warrant exercise, and risks described in Root’s Form 10-K and Forms 10-Q.

Facts investors should verify

  • Whether the Carvana investment and preferred stock issuance actually closed, and the date and terms of closing.
  • Whether the five-year commercial agreement and integrated platform were executed and implemented.
  • Subsequent filings describing warrant vesting, exercise prices, share-count dilution, and Carvana’s ownership percentage.
  • Root’s later disclosures regarding gross written premiums, customer acquisition costs, cash balances, operating losses, and liquidity after the investment.
  • Any required antitrust, insurance-regulatory, or other approvals and any amendments or termination of the Investment Agreement.